Correlation Between Mereo BioPharma and Amundi Treasury

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Amundi Treasury at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Amundi Treasury into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Amundi Treasury Bond, you can compare the effects of market volatilities on Mereo BioPharma and Amundi Treasury and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Amundi Treasury. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Amundi Treasury.

Diversification Opportunities for Mereo BioPharma and Amundi Treasury

0.42
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Mereo and Amundi is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Amundi Treasury Bond in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amundi Treasury Bond and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Amundi Treasury. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amundi Treasury Bond has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Amundi Treasury go up and down completely randomly.

Pair Corralation between Mereo BioPharma and Amundi Treasury

Assuming the 90 days trading horizon Mereo BioPharma Group is expected to under-perform the Amundi Treasury. In addition to that, Mereo BioPharma is 5.08 times more volatile than Amundi Treasury Bond. It trades about -0.06 of its total potential returns per unit of risk. Amundi Treasury Bond is currently generating about -0.1 per unit of volatility. If you would invest  767.00  in Amundi Treasury Bond on September 10, 2024 and sell it today you would lose (37.00) from holding Amundi Treasury Bond or give up 4.82% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Mereo BioPharma Group  vs.  Amundi Treasury Bond

 Performance 
       Timeline  
Mereo BioPharma Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Amundi Treasury Bond 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Amundi Treasury Bond has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Amundi Treasury is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Mereo BioPharma and Amundi Treasury Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mereo BioPharma and Amundi Treasury

The main advantage of trading using opposite Mereo BioPharma and Amundi Treasury positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Amundi Treasury can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amundi Treasury will offset losses from the drop in Amundi Treasury's long position.
The idea behind Mereo BioPharma Group and Amundi Treasury Bond pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets